Sunnyvale, United States
ClearLight Biotechnologies is a biotechnology startup founded in 2014, with a focus on developing innovative 3D technology for unparalleled visualization and quantification of tissue microenvironments. Previously known as ClearLight Diagnostics, LLC, the company is at the forefront of advancing a state-of-the-art, three-dimensional (3D) technology designed for tissue processing and analysis. This pioneering approach offers an exceptional method to observe and measure three-dimensional interactions within the microenvironment of diseased tissues.
The company's CLARITY technology has garnered attention for providing unique tools for tissue processing, examination, and analysis, enabling a more profound comprehension of the tissue microenvironment. This, in turn, supports the discovery of novel biomarkers and the identification of potential therapeutic targets. ClearLight Biotechnologies recently received a $2.77M Venture Round investment on 02 February 2018, which reaffirms the industry's confidence in the value and potential of their innovative technologies and solutions.
As ClearLight Biotechnologies continues to make strides in the biotechnology industry, the recent investment stands as a testament to the company's promising trajectory and the potential impact of their 3D technology in unveiling new insights within tissue microenvironments. This funding is poised to further propel their research and development efforts, solidifying their position as a compelling player in the biotechnology landscape.
